Atillasoy Ercem
SEC CIK 1818802 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | See Remarks | 132.9K | — | $134.9K | 9 | 2021-10-21 | 2022-10-20 |
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
Atillasoy Ercem made no open-market trades at KLRS in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2022-10-26 | 2022-10-20+ | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $8.72 | -2,095 | 132.9K | -2% | -$18.3K |
| M | 2022-10-24 | 2022-10-19+ | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $8.72 | -2,095 | 132.9K | -2% | -$18.3K |
| 2022-07-22 | 2022-07-21 | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $5.38 | -1,533 | 133.5K | -1% | -$8,248 | |
| 2022-07-21 | 2022-07-20 | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $5.21 | -563 | 135.0K | -0.4% | -$2,933 | |
| D | 2022-07-06 | 2022-07-01 | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | A - Grant | $0.00 | +14.0K | 135.6K | +12% | $0 |
| M | 2022-04-22 | 2022-04-20+ | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $6.04 | -2,040 | 121.6K | -2% | -$12.3K |
| D | 2022-04-04 | 2022-01-18 | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | A - Grant | $0.00 | +23.3K | 123.6K | +23% | $0 |
| 2022-01-26 | 2022-01-25 | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $8.24 | -4,639 | 100.3K | -4% | -$38.2K | |
| 2021-10-25 | 2021-10-21 | KLRS | Kalaris Therapeutics, Inc. | Atillasoy Ercem | See Remarks | S - Sale | $24.23 | -1,514 | 105.0K | -1% | -$36.7K |
Purchase Sale Sale after option exercise All abbreviations